Danaher 

$197.93
1348
+$4.21+2.17% Thursday 20:00
+$0.00+0%Thursday 23:52After hours

Statistics

Day High
198.23
Day Low
194.47
52W High
242.8
52W Low
160.93
Volume
3,993,977
Avg. Volume
4,614,981
Mkt Cap
140.09B
P/E Ratio
38.02
Dividend Yield
0.81%
Dividend
1.6

Upcoming

Dividends

0.81%Dividend Yield
Jul 26
$0.40
Apr 26
$0.40
Jan 26
$0.32
Oct 25
$0.32
Jul 25
$0.32
10Y Growth
12.5%
5Y Growth
13.75%
3Y Growth
15.07%
1Y Growth
25%

Earnings

21JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.63
1.83
2.03
2.23
Expected EPS
1.834364
Actual EPS
N/A

Financials

14.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
49.14BRevenue
7.23BNet Income

Analyst Ratings

236.80Average Price Target
The highest estimate is 275.00.
From 16 ratings within the last 6 months. This is not an investment recommendation.
Buy
81%
Hold
19%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DHR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap190.65B
Thermo Fisher Scientific competes directly with Danaher in the life sciences and diagnostics sectors, offering similar products and services.
Abbvie
ABBV
Mkt Cap447.62B
AbbVie, through its acquisition of Allergan, competes in the biopharmaceuticals sector, overlapping with Danaher's life sciences division.
GE Aerospace
GE
Mkt Cap385.54B
General Electric's healthcare division competes with Danaher in medical diagnostics and research products.
Becton Dickinson
BDX
Mkt Cap42.96B
Becton, Dickinson and Company offers a range of medical devices and laboratory equipment, competing with Danaher's life sciences and diagnostics segments.
Resmed
RMD
Mkt Cap29.05B
ResMed competes in the medical devices sector, particularly in products for sleep disorders, overlapping with Danaher's respiratory and sleep business.
Stryker
SYK
Mkt Cap127.55B
Stryker operates in the medical technology field, offering products that compete with Danaher's medical and dental products.
Danaher
DHR
Mkt Cap138.86B
Danaher competes with itself through its diverse portfolio of subsidiaries, each operating in similar sectors as its competitors.
Mettler-Toledo International
MTD
Mkt Cap25.54B
Mettler-Toledo International competes in the precision instruments sector, offering products that overlap with Danaher's analytical and diagnostic solutions.
Agilent Technologies
A
Mkt Cap38.41B
Agilent Technologies competes with Danaher in the life sciences, diagnostics, and applied chemical markets, offering similar analytical instruments and services.

About

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Show more...
CEO
Mr. Steven M. Rales
Employees
61000
Country
United States
ISIN
US2358511028

Listings

0 Comments

Share your thoughts

FAQ

What is Danaher stock price today?
The current price of DHR is $197.93 USD — it has increased by +2.17% in the past 24 hours. Watch Danaher stock price performance more closely on the chart.
What is Danaher stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Danaher stocks are traded under the ticker DHR.
Is Danaher stock price growing?
DHR stock has risen by +0.89% compared to the previous week, the month change is a +7.4% rise, over the last year Danaher has showed a -2.51% decrease.
What is Danaher market cap?
Today Danaher has the market capitalization of 140.09B
When is the next Danaher earnings date?
Danaher is going to release the next earnings report on July 21, 2026.
What were Danaher earnings last quarter?
DHR earnings for the last quarter are 2.06 USD per share, whereas the estimation was 1.94 USD resulting in a +6.44% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Danaher revenue for the last year?
Danaher revenue for the last year amounts to 49.14B USD.
What is Danaher net income for the last year?
DHR net income for the last year is 7.23B USD.
Does Danaher pay dividends?
Yes, DHR dividends are paid quarterly. The last dividend per share was 0.4 USD. As of today, Dividend Yield (FWD)% is 0.81%.
How many employees does Danaher have?
As of July 05, 2026, the company has 61,000 employees.
In which sector is Danaher located?
Danaher operates in the Health & Wellness sector.
When did Danaher complete a stock split?
The last stock split for Danaher was on July 05, 2016 with a ratio of 1319:1000.
Where is Danaher headquartered?
Danaher is headquartered in Washington, United States.